Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(14 sites)
United States
IC Study LLC, Escondido, California University of California Los Angeles Center for Women's Pelvic Health, Los Angeles, California The Clark Center for Urogynecology, Newport Beach, California The Continence Center Medical Group, Inc dba Southern California Continence Center, Newport Beach, California University of California San Diego Medical Center, San Diego, California Prestige Medical Group, Tustin, California United Research Institute, Hialeah, Florida Florida Urology Partners, Tampa, Florida Georgia Urology, Cartersville, Georgia Southern Clinical Research Associates LLC, Metairie, Louisiana Bay State Clinical Trials, Watertown, Massachusetts Sheldon Freedman MD LTD, Las Vegas, Nevada Northwell Health, Lake Success, New York The Wake Forest Institute of Regenerative Medicine, Winston-Salem, North Carolina Last updated January 2026